Prism Medico & Pharmacy Ltd (512217) — Voting Results | 22 September 2026

At the 24th AGM held on 19 September 2026 via video conferencing, shareholders approved all 8 resolutions with near-unanimous support, including adoption of standalone financial statements, reappointment of director Davender Singh, appointment of auditors Garg Mendiratta & Associates, approval of secretarial auditors SDK & Associates, and special resolutions for preferential issue variation, investment in Infuze Well Private Limited, and related party transactions. Voting through NSDL's e-voting platform showed 99.99% approval across ordinary resolutions and 100% for special resolutions, with negligible invalid votes. Governance implications remain minimal given the high approval rates and compliance with SEBI and Companies Act mandates.